Intas Pharmaceuticals Limited Carmustine Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Carmustine Export Records India — #3 Exporter, 44 Shipments, $778.2K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Carmustine

India Pharmaceutical Trade Intelligence

$22.5M50 Suppliers54 CountriesHS 30049049

ExportsIndia → UNITED KINGDOM58.1%India → CANADA12.6%

ImportsAUSTRALIA → India$6.1K TAIWAN → India$153

#1 Supplier: EMCURE PHARMACEUTICALS

Intas Pharmaceuticals Limited — Carmustine Exporter #3 | $778.2K Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Carmustine Exporter Profile

Indian Pharmaceutical Exporter · #3 for Carmustine · $778.2K export value · DGFT Verified

Intas Pharmaceuticals Limited is the #3 Indian exporter of Carmustine with $778.2K in export value and 44 verified shipments. Intas Pharmaceuticals Limited holds a 4.6% market share in Carmustine exports across 6 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Carmustine Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Carmustine export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Carmustine?

Country	Value	Shipments	Share
NETHERLANDS	$230.9K	20	62.4%
UNITED STATES	$108.4K	3	29.3%
FRANCE	$23.5K	2	6.4%
UNITED KINGDOM	$4.9K	2	1.3%

Who Are the Top Buyers of Carmustine from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
BROCACEF NL:HUB BROCACEF HEALTHCAR	NETHERLANDS	$126.7K	8
EVERSANA LIFE SCIENCES SERVICES,LLC	UNITED STATES	$108.4K	3
BROCACEF NL : DUTCH	NETHERLANDS	$59.5K	3
ALLOGA FRANCE	FRANCE	$23.5K	2
BROCACEF NL : HUB	NETHERLANDS	$15.1K	1
BROCACEF NL DUTCH	NETHERLANDS	$11.6K	2
BROCACEF NL:HUB BROCACEF HEALTHCAR	NETHERLANDS	$10.3K	2
TO THE ORDER	UNITED KINGDOM	$4.9K	2
BROCACEF NL HUB	NETHERLANDS	$3.6K	2
BROCACEF NL HUB BROCACEF HEALTHCAR	NETHERLANDS	$2.4K	1

Intas Pharmaceuticals Limited supplies Carmustine to 16 buyers globally. The largest buyer is BROCACEF NL:HUB BROCACEF HEALTHCAR (NETHERLANDS), followed by EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES) and BROCACEF NL : DUTCH (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Carmustine Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS & MEDI: CARMUSTINE 100MG/V,	$176.1K	8
PHR DRUGS&MEDI CARMUSTINE 300MG/V, 1VCON	$100.0K	2
PHR DRUGS&MEDI CARMUSTINE 100MG/V,1VPOW+	$20.0K	1
PHARMA DRUGS & MEDI CARMUSTINE 100MG/V,1	$15.1K	1
PHARMA DRUGS & MEDI CARMUSTINE 300MG/V,	$8.4K	1
PHARMA DRUGS & MEDI CARMUSTINE 100MG/V,1VPOW+1VDILACCORD-NL AS PER DOCUMENT	$6.6K	1
PHARMA DRUGS & MEDI: CARMUSTINE 100MG/V,1VPOW+1VDIL(ACCORD-NL 1118X1X1VIAL	$6.5K	1
PHARMA DRUGS & MEDI: CARMUSTINE 100MG/V1VPOW+1VDIL (ACO-ESPT 1477X1X1VIALVLS	$6.0K	1
PHARMA DRUGS MEDI CARMUSTINE 100MG V 1VPOW 1VDIL ACCORD NL 1005X1X1VIAL	$5.1K	1
PHARM DRUG&MED:CARMUSTINE 100MG/V,1VPOW+1VDIL(ACCORD-UK) EACH VIAL CONTAINS CARMUSTINE PH.EUR.....100 MG	$4.9K	2

Intas Pharmaceuticals Limited exports 29 distinct Carmustine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDI: CARMUSTINE 100MG/V, with 8 shipments worth $176.1K.

How Does Intas Pharmaceuticals Limited Compare to Nearest Carmustine Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	EMCURE PHARMACEUTICALS LIMITED	$4.0M	81	19	$50.0K
2	MSN LABORATORIES PRIVATE LIMITED	$850.0K	17	4	$50.0K
3	INTAS PHARMACEUTICALS LIMITED ★	$778.2K	44	6	$17.7K
4	THERDOSE PHARMA PRIVATE LIMITED	$455.2K	22	8	$20.7K
5	SP ACCURE LABS PRIVATE LIMITED	$229.6K	23	7	$10.0K

Intas Pharmaceuticals Limited ranks #3 among 50 Indian Carmustine exporters. Average shipment value of $17.7K compared to the market average of $129.7K. The closest competitors by value are EMCURE PHARMACEUTICALS LIMITED and MSN LABORATORIES PRIVATE LIMITED.

Which Indian Ports Ship Carmustine Exports?

Port	Shipments	% Share
SAHAR AIR	67	19.7%
SAHAR AIR CARGO ACC (INBOM4)	45	13.2%
HYDERABAD AIR	38	11.2%
HYDERABAD ACC (INHYD4)	28	8.2%
AHEMDABAD AIR ACC (INAMD4)	23	6.8%
Bombay Air	18	5.3%
DELHI AIR	15	4.4%
AHEMDABAD AIR	11	3.2%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Carmustine Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Carmustine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 46 individual customs records matching Intas Pharmaceuticals Limited exporting Carmustine, covering 29 formulations to 6 countries via 16 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 54+ countries, 135+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Carmustine

Carmustine

Intas Pharmaceuticals Limited — Carmustine Exporter Profile

Intas Pharmaceuticals Limited — Carmustine Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Carmustine?

Who Are the Top Buyers of Carmustine from Intas Pharmaceuticals Limited?

What Is India's Total Carmustine Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Carmustine Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Carmustine Exporters?

What Carmustine Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Carmustine to Key Markets

United States — FDA

How Does Intas Pharmaceuticals Limited Compare to Nearest Carmustine Exporters?

Which Indian Ports Ship Carmustine Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Carmustine Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Carmustine Export Data from Intas Pharmaceuticals Limited

Carmustine Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source